Geron
GERN
#6485
Rank
A$1.34 B
Marketcap
A$2.10
Share price
0.00%
Change (1 day)
0.41%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -A$53.88 Million

According to Geron's latest financial reports the company's current earnings are A$0.19 Billion. In 2025 the company made an earning of -A$72.02 Million, an increase over its 2024 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$53.88 Million-25.18%
2025 -A$72.02 Million-67.42%
2024 -A$0.23 Billion-11.23%
2023 -A$0.25 Billion30.22%
2022 -A$0.2 Billion20.15%
2021 -A$0.16 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$44.02 Million8.84%
2017 -A$40.44 Million-3.08%
2016 -A$41.72 Million-22080.6%
2015 A$0.18 M-100.38%
2014 -A$50.41 Million-7.14%
2013 -A$54.29 Million
2011 -A$0.13 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$99.48 Million-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$89.01 Million32.68%
2006 -A$67.09 Million25.59%
2005 -A$53.42 Million4.36%
2004 -A$51.19 Million19.73%
2003 -A$42.75 Million-15.46%
2002 -A$50.57 Million1.94%
2001 -A$49.61 Million33.59%
2000 -A$37.13 Million27.53%
1999 -A$29.12 Million63.13%
1998 -A$17.85 Million15.6%
1997 -A$15.44 Million-10.66%
1996 -A$17.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$15.19 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.51 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$98.08 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.22 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$21.13 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA